Ruijin Hospital: Coronary Artery Disease trials

The registry lists 13 Coronary Artery Disease studies with Ruijin Hospital as lead sponsor. 9 are open to participants now and 0 have results posted.

Early Phase 1 1No phase 12(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• CCTA-Based vs CAG-Based CABG: A Multicenter Pragmatic Non-Inferiority TrialRecruitingNCT07769008Not applicable
• Effects of Icosapent Ethyl on Coronary Plaque, Inflammation, and Ventricular RemodelingNot yet recruitingNCT07641257
• PRogression of Atheroma Evaluated by CT Angiography and IntraCoronary Imaging tEchniquesRecruitingNCT06794684
• Risk Evaluation by COronary Imaging and Artificial intelliGence Based fuNctIonal analyZing tEchniques - IVRecruitingNCT06793787
• Risk Evaluation by COronary Imaging and Artificial intelliGence Based fuNctIonal analyZing tEchniques - IIIRecruitingNCT06793774
• Risk Factors and Outcomes in Coronary Chronic Total OcclusionRecruitingNCT06137521
• Risk Evaluation by COronary CTA and Artificial intelliGence Based fuNctIonal analyZing tEchniques - IRecruitingNCT05884008
• Risk Evaluation by COronary CTA and Artificial IntelliGence Based fuNctIonal analyZing tEchniques - IIRecruitingNCT05856110
• CArdioMetabolism and Atherosclerotic PlaqUe progreSsionRecruitingNCT05117424
• The 10-Year Extended Follow-up of the DACAB TrialCompletedNCT07480629
• First-in-Human Pilot Study of Epicardial Circular RNA-HM2002 Injection in CABG for Ischemic Heart FailureCompletedNCT06621576Early Phase 1
• Quantitative Flow Ratio on Radial Artery Graft Outcome After Coronary Artery Bypass GraftingCompletedNCT05556590
• Risk Factors for Predictors of MACEs After RA-CABGCompletedNCT04935086